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Successful treatment of cardiogenic shock by stenting of the left main
coronary artery in acute myocardial infarction
Uspešno lečenje kardiogenog šoka uzrokovanog akutnim infarktom miokarda
zbog stenoze i tromboze glavnog stabla leve koronarne arterije implantacijom
stenta
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Abstract
Introduction. Patients with non-ST elevation acute coronary
syndromes (NSTE-ACS) are sometimes severely hemodynami-
cly compromised. Urgent coronary angiography should be per-
formed in these patients in percutaneous coronary intervention
(PCI) centers according to the ESC NSTE-ACS guidelines to
determine suitabilty for percutaneous or surgical revasculariza-
tion. Case report. We reported a 62-year-old male with chest
pain admitted to the Coronary Care Unit. ST segment depres-
sion of 2 mm in leads I, L and V4-6 was revealed at electrocar-
diogram. After following 6 hours the patient had chest pain
and signs of cardiogenic shock despite of the therapy. Chest x-
ray showed pulmonary edema. Echocardiographic examination
showed dyskinetic medium and apical segments of septum.
The patient underwent coronary angiography immediately
which revealed 75% stenosis of the left main coronary artery
with thrombus. The use of a GPIIb/III inhibitor-tirofiban and
stent implantation resulted in TIMI III flow. After that the pa-
tient had no chest pain and acute heart failure subsided in the
following days Echocardiography done at the fourth day from
PCI showed only hypokinesis medium and apical segment of
septum. The patient was discharged at day 11 from admission
in a stable condition. Conclusion. Stenting of left main coro-
nary artery stenosis in patients with cardiogenic shock and non-
ST segment elevation acute coronary syndromes may be a life
saving procedure.
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Apstrakt
Uvod. Bolesnici sa akutnim koronarnim sindromom (AKS)
bez ST elevacije ponekad su teško hemodinamski kompromi-
tovani. Takvim bolesnicima treba izvršiti urgentnu koronaro-
grafiju u centrima za perkutane koronarne intervencije (PKI)
prema preporukama Evropskog kardiološkog društva za AKS
bez ST elevacije radi procene pogodnosti za perkutanu ili hiru-
šku revaskularizaciju. Prikaz bolesnika. Bolesnik, star 62 go-
dine, sa bolom u grudima primljen je u Koronarnu jedinicu. Na
EKG-u registrovana je depresija ST segmenta 2 mm u odvo-
dima Dl, aVL i V4-6. Narednih šest sati od prijema i pored te-
rapije bolesnik je imao anginozne bolove i kliničke znake kardio-
genog šoka. Na radiografiji pluća nađen je plućni edem. Ehokar-
diografskim ispitivanjem nađeni su diskinetični srednji i apikalni
segmenti septuma. Bolesniku je odmah urađena koronarografija
koja je pokazala 75% stenozu glavnog stabla leve koronarne arte-
rije sa trombom. Dat je inhibitor GpIIb/IIIa – tirofiban i im-
plantiran je stent nakon čega je registrovan TIMI III (thrombolysis
in myocardial infarction) protok. Narednih dana bolesnik je bio bez
bola u grudima i bez znakova srčane insuficijencije. Ehokardio-
grafski pregled koji je izvršen četvrtog dana od PKI pokazao je
samo hipokineziju srednjeg i apikalnog segmenta septuma. Bole-
snik je otpušten 11. dana u stabilnom stanju. Zaključak. Postav-
ljanje stenta kod stenoze glavnog stabla leve koronarne arterije
kod bolesnika sa kardiogenim šokom i akutnim koronarnim sin-
dromom bez ST elevacije može biti životno spašavajuća proce-
dura.
Ključne reči:
infarkt miokarda; elektrokardiografija; angiografija
koronarnih arterija; tromboliza, terapijska; stentovi.
Introduction
Congestive heart failure (CHF) is a common complica-
tion in patients presenting with non-ST segment elevation
acute coronary syndrome (ACS) strongly associated with ad-
verse clinical outcomes 
1. There are the results which dem-
onstrate CHF incidence of approximately 5% in these pa-
tients 
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ST-elevation myocardial infarction (STEMI) and
  non-ST-
elevation myocardial infarction (NSTEMI) and there is a
high mortality and morbidity in each 
2. The
 SHOCK (Should
we emergently revascularize occluded coronaries
 for cardio-
genic shock) studies find out that approximately 20%
 of all
cardiogenic shock complicating are associated with
NSTEMI. The data from TIMI-3B show that the incidence of
left main coronary artery narrowing in patients with unstable
coronary syndromes is 4 to 8% 
3.
Nonrandomized studies report markedly
 lower mortality
rates among patients who have already undergone revascu-
larization
 for shock 
4. In a cohort of 27 patients with cardio-
genic shock complicating AMI, O’Neill et al. 
5 reported an
in-hospital mortality rate of 67%. The rate was dramatically
reduced to 25% in patients treated with successful emer-
gency angioplasty of the infarct-related artery.
Emergency cardiac catheterization and possible angio-
plasty is an instrument in saving life of patients, particulary
when left main coronary artery (LMCA) stenosis is present 
6, 7.
ADMIRAL trial was a study designed to examine the
effects of abciximab on primary stenting in 300 patients with
AMI. There was a significant 59% reduction at 30 days in
the composite end point of death, recurrent myocardial in-
farction or urgent target vessel revascularization in the stent-
abciximab group compared with the stent-placebo group 
8.
Also, emergency coronary artery bypass grafting
(CABG) is effective but time-consuming and carries the risk
of extensive, irreversible myocardial damage 
9. Lee et al. 
10
have recently reported 1-year unprotected-LMCA PCI out-
comes that are equivalent to outcomes from CABG.
One of the most commonly used methods for mechani-
cal circulatory supprt is an intra-aortic balloon pump coun-
terpulsation and is a class I recommendation from the
American College of Cardiology/American Heart Associa-
tion guidelines for management of acute myocardial infarc-
tion in the presence of cardiogenic shock 
11.
Case report
A 62–year old man was admitted to a Coronary Care
Unit. He had typical anginal pain of 10 min duration, with
back irradiation on effort and at rest a couple of days before
the admittance. On admission he had more intensive and fre-
quent chest pain. He had only one of classical risk factors for
coronary artery disease – smoking. The data of personal his-
tory – by-pass grafting of both femoral artery 7 years ago.
On physical examination the patient appeared generally well.
Blood pressure (BP) was 115/85 mmHg. The electrocardio-
gram (ECG) showed ST segment depression of 2 mm in
leads I, L and V4-6 (Figure l). After the admission the pa-
tient had persistent chest pain, BP was 80/60 mmHg pulmo-
nary edema developed (Killip grade III/IV) and diuresis
stopped. Electrocardiographic changes were the same except
tachycardia. On admission biomarkers were positive: creatin
kinase (CK) 1825 IU/l, troponin I 110 μg/l. Other laboratory
analysas were: glucose 8.2 mmol/l, urea 5.0 mmol/l, creat-
inine 116.2 μmol/l, cholesterol 4,8 mmol/l, HDL cholesterol
0.75 mmol/l, LDL cholesterol 3.43 mmol/l, triglycerides l.6
mmol/l, arterial blood gases: oxygen partial pressure (pO2)
6.86 mm Hg, oxygen saturation (sO2) 84%, carbon dioxide
partial pressure (pCO2) 4.03 mm Hg, pH 7.38. Next day glu-
cose was 5.2 mmol/L, AST (aspartate aminotransfenase)
232.7 IU/l, ALT (alanine aminotransferase) 55.7 IU/l, C-
reactive protein (CRP) 149.9 mg/l and BNP (brain natriuretic
peptide) 392.8 pmol/l.
Fig. l – The admission electrocardiography shows ST dep-
ression of l mm in leads l, L V4-6
Chest x-ray showed very prominent pulmonary stasis
(Figure 2). Echocardiographic finding was: end-diastolic
diametar (EDD) 6.7 cm, end-systolic diametar (ESD) 5.5 cm,
left ventricular ejection fraction (LVEF) 35% (assessed by
Simson's equation), medium and apical segments of septum
were dyskinetic. The patient was treated with enoxaparine,
aspirin, nitrates, dopamine, furosemide, digoxin and oxygen
and underwent coronary angiography 6 hours after the ad-
mission. The coronarography showed 75% stenosis of
LMCA with thrombus (Figure 3). The coronary angiogram
of the other coronary artery was normal. Tirofiban was given
per standard protocol (17 ml bolus continued for 36 h infu-
sion of 15 ml/h) with 600 mg of clopidogrel and thereafter
direct stenting with Taxus 3,5 × 12 mm and inflated to 10
bars for 30 seconds. Subsequent coronary angiography
showed TIMI III flow without residual stenosis of LMCA
(Figure 4). The procedure was without complications. After
Fig. 2 – Evidence of very prominent pulmonary stasis on the
admission dayVolumen 65, Broj 10 VOJNOSANITETSKI PREGLED Strana 771
Knežević B, et al. Vojnosanit Pregl 2008; 65(10): 769–773.
that the patient had no chest pain. Next days pulmonary find-
ing was normalized, chest x-ray was also normal (Figure 5).
Echocardiography finding performed after the fourth day
was: EDD 5.8 cm, ESD 4.6 cm, EF 0.50 (assessed by Sim-
son's equation) with mild hypokinesis medium and apical
segments of septum (Figure 6). All valves were normal, aor-
tic root dimension 3.5 cm, left atrial dimension 3.8 cm and
right ventricular dimension 2.5 cm (assessed by Simson's
equation). At dischage ECG registred ST depression of 0.5
mm in leads I, L, V3-6 with neg. T waves (Figure 7). The
patient was discharged from the hospital at day 11 in stable
condition free of chest pain and other cardiac symptoms with
aspirin, clopidogrel, metoprolol, simvastatine, captoprile,
isosorbide-dinitrate, furosemide 40 mg, spironolactone 25
mg and potassium.
Fig. 6 –  Echocardiography  performed after four days
showed EF 0.50 and mild hypokinesis of medium and apical
segments of septum
Fig. 7 – Electrocardiography at dischage: ST depression of
0,5 mm in leads I, L, V3-6
Discussion
The patient had cardiogenic shock as the consequence
of NSTEMI caused by reversible ischemia rather than myo-
cardial ischemic necrosis demonstrated by good left ven-
tricular ejection fraction (LVEF) after a successful and early
stenting left main coronary artery (LMCA). Patients with
acute heart failure due to ischemia may respond to treatment
and myocardial dysfunction can return to normal when is-
chemia is reversible. Patients with ACS are at substantially
increased risk of recurrent ischemic events and death during
the acute phase (OASIS-2). There is an increased risk of
heart failure development in patients with NSTEMI com-
pared with patients with unstable angina, suggesting that
myocardial cell necrosis is an important determinant for
Fig. 3 – Coronary angiography revealed significant stenosis
of the left main left coronary artery with thrombus
(arrowhead)
Fig. 4 – After direct stenting with Taxus  normal flow to the
vessel was reestablished
Fig. 5 – Chest X-ray four days after stenting was normalStrana 772 VOJNOSANITETSKI PREGLED Volumen 65, Broj 10
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heart failure development in patients with ACS 
l. The second
mechanism of heart failure, is a reversible myocardial stun-
ning and third preexisting impairment of the left ventricular
function. Heart failure (HF) in the patients with ACS on ad-
mission is associated with a marked increase in mortality rate
during hospitalization (the Global Registry of Acute Coro-
nary Events – GRACE). Invasive strategy is associated with
a better outcome in NSTEMI patients at high risk and as
demonstrated in TACTICS-TIMI 18 when a GP IIb/IIIa in-
hibitor is used 
12. The ISAR-COOL (Intracoronary Stenting
with Antithrombotic Regimen Cooling-off) trial randomized
410 intermediate – to high-risk patients to very early angiog-
raphy and revascularization versus a delayed invasive strat-
egy. All the patients were treated with intensive medical
therapy that included aspirin, heparin, clopidogrel (600 mg
loading dose), and the intravenous GP IIb/IIIa receptor in-
hibitor tirofiban. A very early invasive strategy was associ-
ated with significantly better outcome at 30 days.
Therapy of ischemia relieves not only symptoms but
also prevent and attenuate ventricular remodeling and pro-
gression of HF thereby improving prognosis 
13. In NSTEMI
there exists nontransmural myocardial ischemia and enzyme
rise is associated with myocardial necrosis. Echocardiogra-
phy may demonstrate myocardial ischaemia and possible
myocardial salvage after angioplasty. In LE MANS study the
patients with LMCA treated PCI had improved significantly
LVEF in comparison with the CABG group at 1 year 
14.
Cardiac troponins are the preferred markers because of
their diagnostic and risk stratification purposes and in most
cases their rise has been shown to be associated with bad
outcome 
15. C-reactive protein may be useful in prediction of
the long term prognosis 
16.
In patients with unstable angina and non-ST-elevation
myocardial infarction, high levels of BNP is accompanied by
a two-to threefold greater risk of death and with the occur-
rence of subsequent heart failure, also 
17.
Coronary artery bypass surgery (CABG) has been con-
sidered the therapy of choice for patients with unprotected
LMCA stenoses 
18. The favorable Veterans Administration
surgical trial and poor initial angioplasty results in patients
with LMCA stenoses have made coronary artery bypass sur-
gery (CABG) the accepted therapy of choice for patients with
LMCA stenosis and a gold standard. However, elective angio-
plasty and stenting of the left main coronary artery in selected
patients was associeted with a high immediate success rate 
18.
Conventional LM coronary artery angioplasty due to mortality
which was 65% at 20 months has been restricted to patients for
whom surgery is a high-risk procedure and to those who need
urgent treatment 
18. Our patient was severely hemodynamicly
compromised and prompt revascularization by means of
LMCA stenting was a turning point in saving his life. Also,
previous studies have demonstrated low in-hospital complica-
tion rates with unprotected LM stentning. However, in the
study which determined long term clinical outcomes in pa-
tients with ostial or bifurcation LM stentning adverse events
(myocardial infarction, sudden death) occurred during the fol-
low-up period (mean 28 mos) in both groups with equal fre-
quency. The two-year outcomes of the patients with unpro-
tected LM stenosis who were treated with drug-eluting stent
(DES) compared with those treated with bare-metal stent
(BMS) were evaluated and showed lower incidences of car-
diac death and stent thrombosis in DES groups. The results at
1-year of retrospective analysis which was performed to adjust
for the differences between the patients with LM stenosis
treated with DES implantation or coronary artery bypass
grafting (CABG) did not reveal the differences in the oc-
curence of major adverse cardiac and cerebrovascular event 
19.
In the study of unprotected LM stenting versus bypass surgery
(LE MANS study) the patients with LM stenosis treated with
percutaneous coronary intervencion had favorable early out-
comes in comparation with patients treated with CABG 
14.
Conclusion
The introduction of stents has increased the number of
indications for LM coronary artery angioplasty making this
procedure safe and effective in selected patients.
Aggressive and immediate treatment by angioplasty and
stenting an unprotected left main coronary artery stenosis may
be effective in the patients with NSTEMI and heart failure.
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